TY - JOUR
T1 - Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia
AU - Chen, Zhining
AU - Hu, Shimin
AU - Wang, Sa A.
AU - Konopleva, Marina
AU - Tang, Zhenya
AU - Xu, Jie
AU - Li, Shaoying
AU - Toruner, Gokce
AU - Thakral, Beenu
AU - Medeiros, L. Jeffrey
AU - Tang, Guilin
N1 - Funding Information:
We would like to extend our appreciation to our colleagues for the helpful discussions and support throughout this study.
PY - 2020
Y1 - 2020
N2 - Rare patients with chronic myeloid leukemia (CML) can present initially in lymphoblastic crisis (LBC) mimicking Ph + B-lymphoblastic leukemia (B-ALL). We retrospectively reviewed 275 adults who diagnosed initially as Ph + B-ALL and identified 28 patients with at least one of three features supporting the diagnosis of CML-LBC: 1) a large discrepancy between the blast count and Ph + clone; 2) Ph + clone persistent when B-ALL in remission; 3) BCR/ABL1 fusion detected in segmented cells. BCR-ABL1 fusions were p210 in 25 patients and p190 in 3 patients. In comparison to patients with Ph + B-ALL, patients with CML-LBC were older; had higher leukocyte and absolute neutrophil counts; higher immature myeloid cells in peripheral blood; lower blast counts; and inferior outcomes. In addition, we prospectively analyzed 26 patients with Ph + B-lymphoblastic leukemia and identified 8 patients with features more consistent with CML-LBC. These findings highlight the importance of distinguishing CML-LBC from de novo Ph + B-ALL.
AB - Rare patients with chronic myeloid leukemia (CML) can present initially in lymphoblastic crisis (LBC) mimicking Ph + B-lymphoblastic leukemia (B-ALL). We retrospectively reviewed 275 adults who diagnosed initially as Ph + B-ALL and identified 28 patients with at least one of three features supporting the diagnosis of CML-LBC: 1) a large discrepancy between the blast count and Ph + clone; 2) Ph + clone persistent when B-ALL in remission; 3) BCR/ABL1 fusion detected in segmented cells. BCR-ABL1 fusions were p210 in 25 patients and p190 in 3 patients. In comparison to patients with Ph + B-ALL, patients with CML-LBC were older; had higher leukocyte and absolute neutrophil counts; higher immature myeloid cells in peripheral blood; lower blast counts; and inferior outcomes. In addition, we prospectively analyzed 26 patients with Ph + B-lymphoblastic leukemia and identified 8 patients with features more consistent with CML-LBC. These findings highlight the importance of distinguishing CML-LBC from de novo Ph + B-ALL.
KW - B-lymphoblastic leukemia
KW - Chronic myeloid leukemia
KW - Philadelphia chromosome
KW - lymphoblastic crisis
UR - http://www.scopus.com/inward/record.url?scp=85088448410&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088448410&partnerID=8YFLogxK
U2 - 10.1080/10428194.2020.1795160
DO - 10.1080/10428194.2020.1795160
M3 - Article
C2 - 32700989
AN - SCOPUS:85088448410
SP - 1
EP - 8
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
SN - 1042-8194
ER -